DNAJB1-PRKACA peptide vaccine

N/A

Report date: 2026/05/07 20:00:36

Base Information

Drug NameDNAJB1-PRKACA peptide vaccine
Drug Alias NameDNAJB1-PRKACA fusion kinase peptide vaccine
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, HepatocellularFibrolamellar hepatocellular carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSidney Kimmel Comprehensive Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesSidney Kimmel Comprehensive Cancer Center
Inactive CompaniesN/A
Active IndicationsCarcinoma, HepatocellularFibrolamellar hepatocellular carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A